In view of the potential relationship between ypTNM and TIL, the prognostic value of post‐chemotherapy TIL and CD4+TIL change was analyzed in patients with ypTNM stage III NCT‐NSCLC. Here, CD4 is linked to non-small cell lung carcinoma.